Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Authored Items
Ibrutinib-Related Atrial Fibrillation: An Anticoagulant Challenge
Zain Al-Jammali, PharmD
,
Brent Beckner, PharmD
,
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - June 2019 Vol 9, No 2
in
Symptom Management Overview
Urine Alkalinization and Methotrexate Clearance: Are These Key to Safe Administration of High-Dose Methotrexate?
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - October 2021 Vol 11, No 5
in
Editorial
,
Chemotherapy
,
Oncology Pharmacy Protocols
Overcoming Resistance: Antibiotic Guidance for Multidrug-Resistant Febrile Neutropenia in Patients with Cancer
Sonya K. Kedzior, PharmD
,
YoungYoon Ham, PharmD
,
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - April 2021 Vol 11, No 2
in
Review Article
,
Adverse Events
,
Antibiotics
,
Drug Resistance
Direct Oral Anticoagulant Therapy for Heparin-Induced Thrombocytopenia—A New Alternative?
Zain Al-Jammali, PharmD
,
Harleen Singh, PharmD, BCACP
,
Joseph Bubalo, PharmD, BCPS, BCOP
,
Joseph Shatzel, MD
JHOP - June 2020 Vol 10, No 3
in
Symptom Management Overview
,
Oral Therapy
Preventing Chemotherapy-Induced Infertility in Female Patients
Shiela McCollam, PharmD, BCPS
,
Colleen Shipman, PharmD, MPH, BCPS
,
Joseph Bubalo, PharmD, BCPS, BCOP
,
Sacha Krieg, MD, PhD, FACOG
JHOP - December 2019 Vol 9, No 4
in
Symptom Management Overview
Anthracycline-Induced Cardiotoxicity in Adults
Linda Blake, PharmD, PhD, BCPS
,
Alison Palumbo, PharmD, MPH, BCOP
,
Amber Diaz, PharmD, BCOP
,
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - December 2018 Vol 8, No 4
in
Symptom Management Overview
HER2 Receptor Antagonist–Associated Cardiotoxicity
Alison Palumbo, PharmD, MPH, BCOP
,
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - Sept 2016 Vol 6, No 3
in
Supportive Care
Hyperuricemia Management
Joseph Bubalo, PharmD, BCPS, BCOP
,
Amber Diaz, PharmD, BCOP
JHOP - June 2015 Vol 5, No 2
in
Supportive Care
Prevention and Treatment of Cytarabine-Induced Keratoconjunctivitis
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - March 2015 Vol 5, No 1
in
Supportive Care
Pharmacy Practice Opportunities: Is This the Time for Change?
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - December 2014 VOL 4, NO 4
Hiccups
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - December 2014 VOL 4, NO 4
in
Supportive Care
Chemotherapy-Induced Peripheral Neuropathy
Joseph Bubalo, PharmD, BCPS, BCOP
JHOP - September 2014 Vol 4, No 3
in
Supportive Care
Last modified: May 3, 2022
